4//SEC Filing
YVER ANTOINE 4
Accession 0000899243-22-026421
CIK 0001847903other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 6:00 PM ET
Size
5.7 KB
Accession
0000899243-22-026421
Insider Transaction Report
Form 4
YVER ANTOINE
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2022-07-18$4.87/sh−20,000$97,312→ 810,597 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2021, as amended.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.74 to $5.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001861878
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 6:00 PM ET
- Size
- 5.7 KB